Literature DB >> 16611125

Porcine cytochrome P450 and metabolism.

Mette Tingleff Skaanild1.   

Abstract

The pig and especially the minipig are becoming increasingly used as a test animal both in pharmacological and toxicological testing of new compounds. The minipig is used because of its size, it is easy to handle and less test substrate is required. When using an animal species for testing it is of importance to know if the test animal's posses the same abilities to metabolize drugs as humans. Some of the P450 enzymes have been characterized in the pig regarding substrate specificity, inhibition and regulation. The porcine enzymes CYP1A, CYP2A and CYP3A all metabolize the same test substrates as the human enzymes, whereas the enzymes CYP2B, CYP2D, and CYP2E in pig on the other hand seem to be different from the human enzymes concerning metabolism of the well know test substrates. Some of the porcine enzymes have been sequenced i.e. CYP1A, CYP2A, CYP2B, CYP2D, CYP2E and CYP3A and not surprisingly the porcine CYPs that metabolize the human test substrates are about 75% identical in cDNA sequences. What is needed is inhibitory antibodies against each of the porcine enzymes, in order to test whether a test compound is metabolized by one or the other enzyme. Until now chemical inhibitors have been used, but they are rarely 100% specific. Anti-human inhibitory antibodies have also been used, but they may not recognize the porcine enzyme and therefore will not inhibit the reaction. Antibodies for immunoblotting would also make it possible to estimate how much of the total P450 the individual enzymes comprise. From what is known about the porcine P450, it can be concluded that the pig seems to be a good test species if CYP1A, CYP2A or CYP3A are involved in the metabolism of the test compound, depending on the contribution of other enzymes in competing pathways.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16611125     DOI: 10.2174/138161206776361183

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  19 in total

Review 1.  A physiologically based pharmacokinetic model of the minipig: data compilation and model implementation.

Authors:  Claudia Suenderhauf; Neil Parrott
Journal:  Pharm Res       Date:  2012-11-21       Impact factor: 4.200

2.  In vitro Phase I- and Phase II-Drug Metabolism in The Liver of Juvenile and Adult Göttingen Minipigs.

Authors:  Els Van Peer; Frank Jacobs; Jan Snoeys; Jos Van Houdt; Ils Pijpers; Christophe Casteleyn; Chris Van Ginneken; Steven Van Cruchten
Journal:  Pharm Res       Date:  2017-01-17       Impact factor: 4.200

3.  Plasma oxylipin profiling identifies polyunsaturated vicinal diols as responsive to arachidonic acid and docosahexaenoic acid intake in growing piglets.

Authors:  Maaike J Bruins; Adrie D Dane; Katrin Strassburg; Rob J Vreeken; John W Newman; Norman Salem; Cynthia Tyburczy; J Thomas Brenna
Journal:  J Lipid Res       Date:  2013-03-29       Impact factor: 5.922

Review 4.  Induced mammary cancer in rat models: pathogenesis, genetics, and relevance to female breast cancer.

Authors:  James L Miller; Arianna P Bartlett; Rebecca M Harman; Prabin Dhangada Majhi; D Joseph Jerry; Gerlinde R Van de Walle
Journal:  J Mammary Gland Biol Neoplasia       Date:  2022-07-29       Impact factor: 2.698

5.  Characterization of Pharmacokinetics in the Göttingen Minipig with Reference Human Drugs: An In Vitro and In Vivo Approach.

Authors:  Floriane Lignet; Eva Sherbetjian; Nicole Kratochwil; Russell Jones; Claudia Suenderhauf; Michael B Otteneder; Thomas Singer; Neil Parrott
Journal:  Pharm Res       Date:  2016-07-28       Impact factor: 4.200

6.  Assessment of juvenile pigs to serve as human pediatric surrogates for preclinical formulation pharmacokinetic testing.

Authors:  Wyatt J Roth; Candice B Kissinger; Robyn R McCain; Bruce R Cooper; Jeremy N Marchant-Forde; Rachel C Vreeman; Sophia Hannou; Gregory T Knipp
Journal:  AAPS J       Date:  2013-04-18       Impact factor: 4.009

7.  Association between SNPs within candidate genes and compounds related to boar taint and reproduction.

Authors:  Maren Moe; Sigbjørn Lien; Torunn Aasmundstad; Theo H E Meuwissen; Marianne H S Hansen; Christian Bendixen; Eli Grindflek
Journal:  BMC Genet       Date:  2009-07-05       Impact factor: 2.797

8.  Effects of ergot alkaloids on liver function of piglets as evaluated by the (13)C-methacetin and (13)C-α-ketoisocaproic acid breath test.

Authors:  Sven Dänicke; Sonja Diers
Journal:  Toxins (Basel)       Date:  2013-01-15       Impact factor: 4.546

9.  Gene expression profiles in liver of pigs with extreme high and low levels of androstenone.

Authors:  Maren Moe; Sigbjørn Lien; Christian Bendixen; Jakob Hedegaard; Henrik Hornshøj; Ingunn Berget; Theo H E Meuwissen; Eli Grindflek
Journal:  BMC Vet Res       Date:  2008-08-06       Impact factor: 2.741

10.  Profiling the impact of medium formulation on morphology and functionality of primary hepatocytes in vitro.

Authors:  Leonard J Nelson; Philipp Treskes; A Forbes Howie; Simon W Walker; Peter C Hayes; John N Plevris
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.